← Eichor
Condition: Plasma Cell Dyscrasias Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Plasma Cell Dyscrasias

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Phase 1/Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT07075510Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Phase 1/Phase 2 · 24 location(s) · Heidelberg Pharma AG · NCT04879043The Indiana Myeloma Registry
Phase N/A · 1 location(s) · Indiana University · NCT03616483Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Longitudinal Data Registry of Plasma Cell Dyscrasia
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT06760052Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Phase N/A · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT01408225Pre-malignant States to Hematologic Malignancies in Firefighters
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT06870760A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Phase N/A · 142 location(s) · Center for International Blood and Marrow Transplant Researc · NCT01351545High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
Phase 1 · 1 location(s) · University of Arkansas · NCT06313502
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.